Catabolic effect in premature infants with early dexamethasone treatment

F. J. Tsai, C. H. Tsai, S. F. Wu, Y. H. Liu, T. F. Yeh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

To evaluate the catabolic effects of dexamethasone therapy on protein metabolism, amino acid concentrations and urinary 3-methylhistidine (3MH) were measured in 28 premature infants who were included in a double-blind controlled study using early dexamethasone therapy in the prevention of bronchopulmonary dysplasia. Fifteen infants received dexamethasone (0.5 mg/kg/day i.v.) and 13 infants received normal saline as control. Heparinized venous blood samples for amino acid analysis were obtained before the study and again at day 5 after starting the study. Urinary 3MH was measured on days 1, 3, 5, 7, 14, 21, and 28 of treatment. A substantial increase in amino acid concentrations was observed in infants receiving dexamethasone. Alanine, glutamine, citrulline, ornithine and cystine concentrations increased twofold or more. The 3MH:creatinine ratio was increased in the treated group. These metabolic effects were most likely due to an increase in protein catabolism.

Original languageEnglish
Pages (from-to)1487-1490
Number of pages4
JournalActa Paediatrica, International Journal of Paediatrics
Volume85
Issue number12
DOIs
Publication statusPublished - Jan 1 1996
Externally publishedYes

Fingerprint

Premature Infants
Dexamethasone
Amino Acids
Bronchopulmonary Dysplasia
Citrulline
Ornithine
Cystine
Therapeutics
Secondary Prevention
Glutamine
Double-Blind Method
Alanine
Creatinine
Proteins
3-methylhistidine

Keywords

  • 3-methylhistidine
  • amino acids
  • bronchopulmonary dysplasia
  • dexamethasone

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Catabolic effect in premature infants with early dexamethasone treatment. / Tsai, F. J.; Tsai, C. H.; Wu, S. F.; Liu, Y. H.; Yeh, T. F.

In: Acta Paediatrica, International Journal of Paediatrics, Vol. 85, No. 12, 01.01.1996, p. 1487-1490.

Research output: Contribution to journalArticle

Tsai, F. J. ; Tsai, C. H. ; Wu, S. F. ; Liu, Y. H. ; Yeh, T. F. / Catabolic effect in premature infants with early dexamethasone treatment. In: Acta Paediatrica, International Journal of Paediatrics. 1996 ; Vol. 85, No. 12. pp. 1487-1490.
@article{14374888ceb84b709ece78de2d10d715,
title = "Catabolic effect in premature infants with early dexamethasone treatment",
abstract = "To evaluate the catabolic effects of dexamethasone therapy on protein metabolism, amino acid concentrations and urinary 3-methylhistidine (3MH) were measured in 28 premature infants who were included in a double-blind controlled study using early dexamethasone therapy in the prevention of bronchopulmonary dysplasia. Fifteen infants received dexamethasone (0.5 mg/kg/day i.v.) and 13 infants received normal saline as control. Heparinized venous blood samples for amino acid analysis were obtained before the study and again at day 5 after starting the study. Urinary 3MH was measured on days 1, 3, 5, 7, 14, 21, and 28 of treatment. A substantial increase in amino acid concentrations was observed in infants receiving dexamethasone. Alanine, glutamine, citrulline, ornithine and cystine concentrations increased twofold or more. The 3MH:creatinine ratio was increased in the treated group. These metabolic effects were most likely due to an increase in protein catabolism.",
keywords = "3-methylhistidine, amino acids, bronchopulmonary dysplasia, dexamethasone",
author = "Tsai, {F. J.} and Tsai, {C. H.} and Wu, {S. F.} and Liu, {Y. H.} and Yeh, {T. F.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1111/j.1651-2227.1996.tb13957.x",
language = "English",
volume = "85",
pages = "1487--1490",
journal = "Acta Paediatrica, International Journal of Paediatrics",
issn = "0803-5253",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Catabolic effect in premature infants with early dexamethasone treatment

AU - Tsai, F. J.

AU - Tsai, C. H.

AU - Wu, S. F.

AU - Liu, Y. H.

AU - Yeh, T. F.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - To evaluate the catabolic effects of dexamethasone therapy on protein metabolism, amino acid concentrations and urinary 3-methylhistidine (3MH) were measured in 28 premature infants who were included in a double-blind controlled study using early dexamethasone therapy in the prevention of bronchopulmonary dysplasia. Fifteen infants received dexamethasone (0.5 mg/kg/day i.v.) and 13 infants received normal saline as control. Heparinized venous blood samples for amino acid analysis were obtained before the study and again at day 5 after starting the study. Urinary 3MH was measured on days 1, 3, 5, 7, 14, 21, and 28 of treatment. A substantial increase in amino acid concentrations was observed in infants receiving dexamethasone. Alanine, glutamine, citrulline, ornithine and cystine concentrations increased twofold or more. The 3MH:creatinine ratio was increased in the treated group. These metabolic effects were most likely due to an increase in protein catabolism.

AB - To evaluate the catabolic effects of dexamethasone therapy on protein metabolism, amino acid concentrations and urinary 3-methylhistidine (3MH) were measured in 28 premature infants who were included in a double-blind controlled study using early dexamethasone therapy in the prevention of bronchopulmonary dysplasia. Fifteen infants received dexamethasone (0.5 mg/kg/day i.v.) and 13 infants received normal saline as control. Heparinized venous blood samples for amino acid analysis were obtained before the study and again at day 5 after starting the study. Urinary 3MH was measured on days 1, 3, 5, 7, 14, 21, and 28 of treatment. A substantial increase in amino acid concentrations was observed in infants receiving dexamethasone. Alanine, glutamine, citrulline, ornithine and cystine concentrations increased twofold or more. The 3MH:creatinine ratio was increased in the treated group. These metabolic effects were most likely due to an increase in protein catabolism.

KW - 3-methylhistidine

KW - amino acids

KW - bronchopulmonary dysplasia

KW - dexamethasone

UR - http://www.scopus.com/inward/record.url?scp=0029800123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029800123&partnerID=8YFLogxK

U2 - 10.1111/j.1651-2227.1996.tb13957.x

DO - 10.1111/j.1651-2227.1996.tb13957.x

M3 - Article

C2 - 9001663

AN - SCOPUS:0029800123

VL - 85

SP - 1487

EP - 1490

JO - Acta Paediatrica, International Journal of Paediatrics

JF - Acta Paediatrica, International Journal of Paediatrics

SN - 0803-5253

IS - 12

ER -